SCHEMBL4511158

SCHEMBL4511158

COc1c(Cl)cc(OCC=C(Cl)Cl)cc1/C=N/O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C19 P33261 2/20 0.44
PKM P14618 1/20 0.44
HSD17B10 Q99714 3/20 0.41
GAA P10253 2/20 0.39
HTT P42858 4/20 0.38
HPGD P15428 7/20 0.36
TSHR P16473 4/20 0.36
KDM4E B2RXH2 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
KMT2A Q03164 4/20 0.35
MAPT P10636 3/20 0.34
MEN1 O00255 3/20 0.34
MAPK1 P28482 1/20 0.33
NPC1 O15118 2/20 0.32
NFKB1 P19838 2/20 0.32
RAB9A P51151 2/20 0.32
NFKB2 Q00653 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4511160 1.00 ALDH1A1 (0.44) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL13614127 0.84 HTT (0.42) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL4505232 0.84 ALDH1A1 (0.39) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL4127222 0.78 HTT (0.36) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL4127220 0.78 HTT (0.36) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL4513392 0.78 HTT (0.40) ALDH1A1CYP1A2CYP3A4CYP2C19HSD17B10
SCHEMBL4513393 0.78 HTT (0.40) ALDH1A1CYP1A2CYP3A4CYP2C19HSD17B10
SCHEMBL4515720 0.77 MAPT (0.52) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL4515723 0.77 MAPT (0.52) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL4502807 0.77 HTT (0.37) ALDH1A1CYP1A2CYP3A4CYP2C19PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042957-A1 Substituted Oxyarenes BAYER CROPSCIENCE AG (DE) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042957-A1 Substituted Oxyarenes CYP1A1, OXER1, CYP1A2 ALDH1A1 544/4885CYP1A2 3/4885CYP3A4 108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.